Amgen (AMGN) Is Up 6.7% After EMA Backs Broader Repatha Use in High-Risk Patients – Has The Bull Case Changed? Simply Wall St 12:49
Global pharma giants turn to Chinese biotech to tap innovation, valuation growth South China Morning Post 11:37
What Vir Biotechnology (VIR)'s Profit Swing But Earnings Miss Means For Shareholders Simply Wall St 08:46
IIT Guwahati develops 'E-Eye' for rapid detection of Cancer-causing heavy metals and other toxicants The Times of India 07:57
Grail Announces FDA Advisory Committee Review Of Galleri Multi-Cancer Early Detection Test RTT News 05:38
AI becoming core infrastructure for pharmaceutical R&D, not just an experimental tool: Report AniNews.in 03:11
Machine learning powered protein engineering lab could accelerate biotech innovation Digital Journal 23:58 Fri, 07 Aug
New Troodontid Dinosaur Genus Identified from Fossil Bone Found Decades Ago in New Mexico Sci.News 22:02 Fri, 07 Aug
US court pauses Pentagon's blacklisting of China's WuXi AppTec Nikkei Asian Review 21:35 Fri, 07 Aug Article paywall
Blossomhill’s $150M IPO to fund macrocyclic cancer drug pipeline BioWorld 21:21 Fri, 07 Aug Article paywall
Latigo raises $346M in IPO for non-opioid Nav1.8 pain pipeline BioWorld 21:21 Fri, 07 Aug Article paywall
Medtronic gains expanded Affera CE mark for ventricular arrhythmias BioWorld 20:49 Fri, 07 Aug Article paywall
Is Biogen (BIIB) Fully Priced After Earnings Raised Revenue But Cut Profit? Simply Wall St 20:43 Fri, 07 Aug
Replimune’s Tudriqev wins FDA accelerated approval for melanoma BioWorld 19:05 Fri, 07 Aug Article paywall
Biotechnology and National Security: Washington’s Expanding Scrutiny of the Life Sciences JD Supra 18:15 Fri, 07 Aug
Weekly Buzz: mRNA, NVS, SNY Gain Approvals; EBS, Lsta Cut Jobs; tars, Bivi Drive Deals & Data RTT News 16:55 Fri, 07 Aug
IPS Heart’s ISX9-CPC designated rare pediatric drug by FDA BioWorld 16:06 Fri, 07 Aug Article paywall
AI-designed phages could combat AMR, but come with biosafety risks BioWorld 16:05 Fri, 07 Aug Article paywall
GeneChem Inc. Receives U.S. FDA NDIN No Objection for Siallac6®, 6'-Sialyllactose Sodium Salt in Collaboration with REJIMUS, INC. PRWeb (Press Release) 16:03 Fri, 07 Aug
Context drops bispecific T-cell engager on cost-cutting initiative Clinical Trials Arena 14:05 Fri, 07 Aug
Nrxp: FDA Clears First-Cycle Review Of Preservation-Free Ketamine Anda; Approval Awaits Vial Cert RTT News 14:02 Fri, 07 Aug
India must build export-oriented medical devices industry, says pharma secretary The Times of India 14:00 Fri, 07 Aug